Alignment Healthcare (ALHC) vs Freenome (FRNM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Freenome (FRNM) has outperformed Alignment Healthcare (ALHC) over the past year, gaining 49.2% versus a loss of 50.8%. Freenome is the larger company by market cap ($1.70 billion vs $1.57 billion), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALHC | FRNM |
|---|---|---|
| Share price | $7.55 | $15.78 |
| Market cap | $1.57B | $1.70B |
| 1-day change | -13.38% | -0.19% |
| YTD return | -55.90% | +21.34% |
| 1-year return | -50.76% | +49.15% |
| 5-year return | -53.22% | — |
| P/E ratio (TTM) | 39.71 | — |
| Forward P/E | 10.27 | — |
| EPS (TTM) | $0.19 | $-2.04 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $3.95B | — |
| Revenue growth (YoY) | +46.06% | — |
| Net income (latest FY) | $-724.00K | $837.47K |
| Operating margin | 0.37% | — |
| Net margin | -0.02% | — |
| 52-week high | $25.12 | $17.50 |
| 52-week low | $6.01 | $9.95 |
| Distance from 52-week high | -69.96% | -9.83% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +172.23% | +14.07% |
| Average volume | 7.55M | 796.45K |
| Shares outstanding | 207.44M | 107.45M |
| Employees | 1,849 | 375 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- FRNM has outperformed ALHC by 99.9 percentage points over the past year.
About Alignment Healthcare
ALHC stock →Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States.
Health Care · Medical Specialities · 1,849 employees
About Freenome
FRNM stock →Freenome, Inc., a biotechnology company, develops blood-based screening tests to detect cancer in the United States. The company offers an early cancer detection platform that integrates multiomics, artificial intelligence, and machine learning to uncover complex biological signals associated with cancer.
Health Care · Medical Specialities · 375 employees
ALHC vs FRNM FAQ
Which is bigger, Alignment Healthcare or Freenome?
Freenome (FRNM) is larger, with a market capitalization of $1.70B compared with $1.57B for Alignment Healthcare (ALHC).
Which stock has performed better over the past year, ALHC or FRNM?
FRNM returned +49.15% over the past 12 months, compared with -50.76% for ALHC (price return, excluding dividends). Past performance does not predict future results.
Are Alignment Healthcare and Freenome in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.